For research use only. Not for therapeutic Use.
Bevonescein (ALM-488) is a novel, intravenously-administrated fluorescein-conjugated peptide that binds nerve-associated connective tissue, labels peripheral nerves under real-time fluorescence imaging (FL) in living mice and human ex vivo nerve tissue. Bevonescein is a peptide-linked tracer which fluorescently labeled both intact and degenerated nerves[1][2].
Bevonescein (ALM-488; 900 nmol; IV; underwent a 90-minute observation period) improves nerve identification for intact, degenerated, and partially regenerated nerves by vivo realtime fluorescence imaging (FL) in female SKH‐1 hairless, wild‐type, ~25 g mice[1].
Catalog Number | I041854 |
CAS Number | 2276787-79-0 |
Molecular Formula | C112H144N22O32 |
Purity | ≥95% |
Reference | [1]. Kayva L Crawford, et al. Identification of Degenerated Murine Facial Nerves With Fluorescence Labeling After Transection Injury. Otolaryngol Head Neck Surg. 2023 Aug;169(2):234-242. [2]. Feredun Azari, et al. Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings. J Biomed Opt. 2021 May;26(5):050901. Feredun Azari, et al. Intraoperative molecular imaging clinical trials: a review of 2020 conference proceedings. J Biomed Opt. 2021 May;26(5):050901. |